CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Calyxo, Inc. recalls CVAC Aspiration System

Read the official FDA notice

Published
2 Apr 2025
Units affected
11,246
Agency
FDA
Country
United States

The hazard

Aspiration system, for endoscopic examination/treatment of urinary tract and kidney interior, to have labeling update adding additional instructions, for patients with high viscosity fluid in the kidney, not to continue providing fluid inflow in the presence of unresolved slow or absent fluid outflow because this can create intrarenal pressure imbalance, and lead to excessive intrarenal pressure.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

CVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic examination/treatment of urinary tract and kidney interior.

Brand / company
Calyxo, Inc.
Codes / lots
CVC127020-1 UDI-DI: 00860005357710, L00018 Rev C
Distribution
US Nationwide distribution including in the states of AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, WV.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 2 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.